A detailed history of Alliancebernstein L.P. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 79,310 shares of IDYA stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,310
Previous 66,500 19.26%
Holding current value
$2.51 Million
Previous $2.92 Million 4.59%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $440,279 - $556,722
12,810 Added 19.26%
79,310 $2.78 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $301,644 - $415,686
8,820 Added 15.29%
66,500 $2.92 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $175,572 - $255,826
7,140 Added 14.13%
57,680 $2.05 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $23,177 - $32,747
1,100 Added 2.22%
50,540 $1.36 Million
Q2 2023

Aug 15, 2023

BUY
$13.33 - $25.53 $235,141 - $450,349
17,640 Added 55.47%
49,440 $1.16 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $68,799 - $95,472
5,100 Added 19.1%
31,800 $436,000
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $62,221 - $78,131
4,300 Added 19.2%
26,700 $485,000
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $200,053 - $335,354
-24,161 Reduced 51.89%
22,400 $309,000
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $478,157 - $1.03 Million
-42,769 Reduced 47.88%
46,561 $521,000
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $71,230 - $91,392
3,400 Added 3.96%
89,330 $2.11 Million
Q2 2021

Jul 30, 2021

BUY
$17.76 - $24.83 $1.3 Million - $1.81 Million
72,930 Added 561.0%
85,930 $1.8 Million
Q1 2021

May 06, 2021

SELL
$13.48 - $23.77 $86,272 - $152,128
-6,400 Reduced 32.99%
13,000 $306,000
Q3 2020

Nov 12, 2020

SELL
$11.22 - $14.46 $19,074 - $24,582
-1,700 Reduced 8.06%
19,400 $244,000
Q2 2020

Aug 13, 2020

BUY
$3.59 - $18.57 $75,749 - $391,827
21,100 New
21,100 $300,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.52B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.